Renalytix Plc RTNXF
Set alert
0.08 +0.08 —
Day range unavailable
52-week range unavailable
- Open
- —
- Prev close
- 0.00
- Mkt cap
- 22.55M
- Vol
- 0
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
More statistics
- Low
- —
- High
- —
Financial health
Altman Z-Score
-22.63 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
4 / 9 Average
Nine pass/fail tests of profitability, leverage and efficiency.
Valuation
P/E -0.5×
FY 2018 5y median -3.2× FY 2024
P/S 7.6×
FY 2018 5y median 24.4× FY 2024
P/B -2.2×
FY 2018 5y median 10.9× FY 2024
P/FCF -0.6×
FY 2018 5y median -2.9× FY 2024
EV/EBITDA -0.7×
FY 2018 5y median -2.0× FY 2024
EV/Sales 9.2×
FY 2018 5y median 20.7× FY 2024
FCF Yield -174.0%
FY 2018 5y median -34.9% FY 2024
Profitability
Gross Margin 6.8%
FY 2018 5y median 21.2% FY 2024
Operating Margin -1293.5%
FY 2018 5y median -1293.5% FY 2024
Net Margin -1461.6%
FY 2018 5y median -1461.6% FY 2024
ROE 426.0%
FY 2018 5y median -36.5% FY 2024
ROIC -4347.7%
FY 2018 5y median -95.5% FY 2024
ROA -419.7%
FY 2018 5y median -71.6% FY 2024
Growth (YoY)
Revenue -32.7%
FY 2018 FY 2024
Operating Income 29.9%
FY 2018 FY 2024
EPS (diluted) 43.6%
FY 2018 FY 2024
Free Cash Flow 11.6%
FY 2018 FY 2024
Financial Health
Current Ratio 0.5×
FY 2018 5y median 3.9× FY 2024
Quick Ratio 0.5×
FY 2018 5y median 3.9× FY 2024
Debt / Equity -1.1×
FY 2018 5y median 0.0× FY 2024
Net Debt / EBITDA -0.1×
FY 2018 5y median 0.5× FY 2024
Interest Coverage 0.0×
FY 2018 5y median 0.0× FY 2024
Dividends
Dividend Yield 0.0%
FY 2018 5y median 0.0% FY 2024
Payout Ratio 0.0%
FY 2018 5y median 0.0% FY 2024
Annual · latest fiscal year ends 2024-06-30